Home > Authorities > Institutes > Record #113776 |
F035
Tumorvirus-spez. Vakzinierungsstrategie Also known as:F035 Tumorvirus-spez. Vakzinierungsstrategie; Tumorvirus-spezifische VakzinierungsstrategienID | I:(DE-He78)F035-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Inter-epitope spacer variation within polytopic L2-based human papillomavirus antigens affects immunogenicity.
npj vaccines 9(1), 44 (2024) [10.1038/s41541-024-00832-0]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Scientific approaches toward improving cervical cancer elimination strategies.
International journal of cancer 154(9), 1537-1548 (2024) [10.1002/ijc.34839]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis.
Arthritis & rheumatology 76(4), 620-630 (2024) [10.1002/art.42746]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2
Frontiers in immunology 14, 1272018 (2023) [10.3389/fimmu.2023.1272018]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2.
Vaccines 11(10), 1582 (2023) [10.3390/vaccines11101582]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses - A meeting report.
Preventive Medicine Reports 35, 102368 (2023) [10.1016/j.pmedr.2023.102368]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.
Frontiers in immunology 13, 1010790 (2022) [10.3389/fimmu.2022.1010790]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
A broadly protective vaccine against cutaneous human papillomaviruses.
npj vaccines 7(1), 116 (2022) [10.1038/s41541-022-00539-0]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines.
Frontiers in immunology 13, 958123 (2022) [10.3389/fimmu.2022.958123]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Isoforms of the Papillomavirus Major Capsid Protein Differ in Their Ability to Block Viral Spread and Tumor Formation.
Frontiers in immunology 13, 811094 (2022) [10.3389/fimmu.2022.811094]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |